More than ever,
we remain
by your side.

COVID-19: PathoQuest services continuity update

The COVID-19 pandemic has continued to rapidly evolve; many countries are facing the challenges of very high global risk levels.  During health emergencies like this pandemic, one of PathoQuest roles is to continue to provide our customers and partners the best services that will help develop the new biologics treatments or vaccines to support health services worldwide. Regulatory bodies encourage our industry to find faster and more accurate solutions for the development or production of new vaccines and treatment. That is why PathoQuest proposes robust and efficient next-generation sequencing-based quality control solutions to reduce time to market and improve patient outcomes. ​ Our team is prepared and has never stopped its activity in 2020.  Rest assured that we are putting all our efforts to maintain our services in accordance with French regulations to control the spread of the pandemic on the territory and to guaranty the safety of our workers. The laboratory activities will not be disturbed, some of our support activities will be performed remotely when possible but our offices and labs remain open and our team is ready to work with you on new projects. We invite you to reach out to us at for any question and we look forward to collaborating with you. With my best regards, On behalf of the whole PathoQuest team Jean-François Brepson President & CEO, PathoQuest

For more information about PathoQuest, click here.